RecruitingNCT04258787

OCT in Fuchs' Dystrophy

Evaluating Corneal Edema in Fuchs' Endothelial Dystrophy Using Optical Coherence Tomography


Sponsor

Oregon Health and Science University

Enrollment

60 participants

Start Date

Jun 26, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

This is an observational study using optical coherence tomography (OCT) technology to quantify corneal edema in Fuchs' endothelial dystrophy and predict refractive shift from resolving corneal edema after surgical treatments.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Damaged or diseased corneal endothelium from Fuchs' or PBK
  • Willingness to commit to required study visits

Exclusion Criteria8

  • Prior Endothelial Keratoplasty (EK) or any other surgery except uncomplicated cataract surgery
  • Presence of a condition that increases the probability for treatment failure (e.g., heavily vascularized cornea, uncontrolled uveitis)
  • Other primary endothelial dysfunction conditions (e.g., posterior polymorphous corneal dystrophy and congenital hereditary corneal dystrophy, iridocorneal endothelial syndrome)
  • Central sub-epithelial or stromal scarring that could impact post-operative clarity assessment
  • Peripheral anterior synechiae in the angle greater than 3 clock hours
  • Hypotony
  • Uncontrolled glaucoma
  • Visually significant optic nerve or macular pathology

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Oregon Health & Science University

Portland, Oregon, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04258787


Related Trials